Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-05-05 16:11:18 ET · period of report 2026-05-05 · accession 0001061983-26-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $39.13 | +11.3K | 69.9K | +19% | +$443.5K |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $77.25 | -11.3K | 58.6K | -16% | -$875.5K |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -11.3K | 13.1K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-05 | M | A | 11,333 | $39.13 | 69,888 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-05 | S | D | 11,333 | $77.25 | 58,555 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-05-05 | M | D | 11,333 | $0.00 | 13,070 | D | $39.13 · 2023-04-06 to 2033-03-06 | 11,333 Common Stock |